To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Pontifax backs UK gene editing company in $10 million A round
Tropic Biosciences is developing decaffeinated coffee varieties and bananas with a longer shelf life using CRISPR gene editing technology that Pontifax managing partner Ben Belldegrun tells Agri Investor is drawing biotech investors into the market.
